Verfügbarkeit: Artificial intelligence for medicine

Artificial intelligence for medicine: people, society, pharmaceuticals, and medical materials

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Oshida, Yoshiki (VerfasserIn)
Format:	Buch
Sprache:	English
Veröffentlicht:	Berlin De Gruyter [2022]
Schriftenreihe:	De Gruyter STEM
Schlagworte:	Künstliche Intelligenz Medizin Arzneimittel Gesellschaft Medizinische Versorgung Intelligenter Werkstoff
Online-Zugang:	https://www.degruyter.com/books/9783110717792 Inhaltsverzeichnis Inhaltsverzeichnis
Beschreibung:	XXVII, 490 Seiten Illustrationen 24 cm x 17 cm
ISBN:	9783110717792 3110717794

Internformat

MARC


LEADER	00000nam a22000008c 4500
001	BV047583848
003	DE-604
005	20231212
007	t\|
008	211111s2022 gw a\|\|\| \|\|\|\| 00\|\|\| eng d
015			\|a 21,N06 \|2 dnb
016	7		\|a 1226451152 \|2 DE-101
020			\|a 9783110717792 \|c : EUR 86.95 (DE) (freier Preis), EUR 86.95 (AT) (freier Preis) \|9 978-3-11-071779-2
020			\|a 3110717794 \|9 3-11-071779-4
024	3		\|a 9783110717792
035			\|a (OCoLC)1286877087
035			\|a (DE-599)DNB1226451152
040			\|a DE-604 \|b ger \|e rda
041	0		\|a eng
044			\|a gw \|c XA-DE-BE
049			\|a DE-384 \|a DE-573 \|a DE-898 \|a DE-29T \|a DE-29 \|a DE-M347
084			\|a XC 4000 \|0 (DE-625)152514:12905 \|2 rvk
084			\|a 660 \|2 23sdnb
100	1		\|a Oshida, Yoshiki \|0 (DE-588)1225432790 \|4 aut
245	1	0	\|a Artificial intelligence for medicine \|b people, society, pharmaceuticals, and medical materials \|c Yoshiki Oshida
264		1	\|a Berlin \|b De Gruyter \|c [2022]
300			\|a XXVII, 490 Seiten \|b Illustrationen \|c 24 cm x 17 cm
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	0		\|a De Gruyter STEM
650	0	7	\|a Künstliche Intelligenz \|0 (DE-588)4033447-8 \|2 gnd \|9 rswk-swf
650	0	7	\|a Medizin \|0 (DE-588)4038243-6 \|2 gnd \|9 rswk-swf
650	0	7	\|a Arzneimittel \|0 (DE-588)4003115-9 \|2 gnd \|9 rswk-swf
650	0	7	\|a Gesellschaft \|0 (DE-588)4020588-5 \|2 gnd \|9 rswk-swf
650	0	7	\|a Medizinische Versorgung \|0 (DE-588)4038270-9 \|2 gnd \|9 rswk-swf
650	0	7	\|a Intelligenter Werkstoff \|0 (DE-588)4274825-2 \|2 gnd \|9 rswk-swf
689	0	0	\|a Künstliche Intelligenz \|0 (DE-588)4033447-8 \|D s
689	0	1	\|a Medizinische Versorgung \|0 (DE-588)4038270-9 \|D s
689	0	2	\|a Gesellschaft \|0 (DE-588)4020588-5 \|D s
689	0	3	\|a Arzneimittel \|0 (DE-588)4003115-9 \|D s
689	0	4	\|a Intelligenter Werkstoff \|0 (DE-588)4274825-2 \|D s
689	0		\|5 DE-604
689	1	0	\|a Medizin \|0 (DE-588)4038243-6 \|D s
689	1	1	\|a Künstliche Intelligenz \|0 (DE-588)4033447-8 \|D s
689	1		\|5 DE-604
710	2		\|a Walter de Gruyter GmbH & Co. KG \|0 (DE-588)10095502-2 \|4 pbl
776	0	8	\|i Erscheint auch als \|n Online-Ausgabe \|z 978-3-11-071785-3
776	0	8	\|i Erscheint auch als \|n Online-Ausgabe \|z 978-3-11-071792-1
856	4	2	\|m X:MVB \|u https://www.degruyter.com/books/9783110717792
856	4	2	\|m DNB Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032969182&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
856	4	2	\|m Digitalisierung UB Augsburg - ADAM Catalogue Enrichment \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032969182&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
943	1		\|a oai:aleph.bib-bvb.de:BVB01-032969182

Datensatz im Suchindex

_version_	1816888268725157888
adam_text	CONTENTS PREFACE - V LIST OF ABBREVIATIONS - XIX ABOUT THE AUTHOR ---- XXIX CHAPTER 1 AL IN GENERAL - 1 1.1 1.2 1.3 1.3.1 1.3.2 1.4 1.4.1 1.4.2 1.5 1.5.1 1.5.2 1.5.3 1.5.4 1.6 1.6.1 1.6.2 UNDEFINED DEFINITION - 1 HISTORY OF AL DEVELOPMENT AND FUTURE ---- 2 NATURE ---- 5 IN GENERAL - 5 AS A PART OF IT ---- 7 CLASSIFICATION - 8 ELEMENTAL TECHNOLOGIES INVOLVED IN AL -----8 THREE ALS ---- 11 ROLE, FUNCTION, AND APPLICATIONS OF AL ---- 13 ROLE ---- 13 FUNCTION - 14 SUPPORTING TECHNOLOGIES ---- 14 APPLICATIONS ---- 17 ADVANTAGES AND DISADVANTAGES ---- 18 ADVANTAGES ---- 18 DISADVANTAGES ---- 18 REFERENCES ---- 19 CHAPTER 2 AL IN INFORMATION ---- 23 2.1 2.1.1 2.1.2 2.2 2.3 DATA VERSUS INFORMATION ---- 23 DATA ---- 24 DATA MINING, INFORMATION, AND DIKW HIERARCHY ---- 25 KNOWLEDGE, INTELLIGENCE, AND INTELLECT ---- 26 AL ONTOLOGY ---- 29 REFERENCES ---- 30 CHAPTER 3 AL IN SOCIETY ---- 32 3.1 3.2 GLOBAL ---- 32 SOCIETAL ---- 35 XII - CONTENTS 3.3 PERSONAL ----- 37 3.3.1 TECHNOLOGICAL ENVIRONMENT --- 37 3.3.2 EXAMPLES OF JOBS THAT ARE LIKELY TO BE SUBSTITUTED BY AL ---- 39 3.3.3 REPRESENTATIVE EXAMPLES OF LESS LIKELY POSITIONS TO BE SUBSTITUTED BY AL ---- 40 3.3.4 NEW-TYPE JOBS THAT AL CREATES ----- 41 3.3.5 WORK-STYLE REFORMATION -----42 3.4 FUTURE OF AL SOCIETY ----- 43 REFERENCES ---- 44 CHAPTER 4 AL IN CONCERN - 47 4.1 DIGITAL CLONE ---- 47 4.2 PERSONALITY ---- 49 4.2.1 LEGAL PERSONALITY ----- 49 4.2.2 PERSONALITY ---- 50 4.2.3 CONSCIOUSNESS, GENDER, AND MARRIAGE ---- 50 4.3 IQ AND COMMON SENSE ---- 52 4.3.1 IQ TEST ---- 52 4.3.2 COMMON SENSE ----- 54 4.3.3 LIE AND SONTAKU ----- 55 4.4 BIAS AND ERRORS ----- 57 4.4.1 BIAS ---- 57 4.4.2 ERRORS ---- 58 4.4.3 COMPUTER VIRUS AND IMMUNE SYSTEM ---- 60 4.5 EQ AND ETHICS ----- 61 4.5.1 EQ---- 62 4.5.2 ETHICS ---- 63 4.5.3 ACCOUNTABILITY ----- 65 4.6 PRIVACY AND ITS RELATED ISSUES ---- 67 4.6.1 PRIVACY ---- 67 4.6.2 TRANSPARENCY AND EXPLAINABILITY 68 4.7 COPYRIGHT ---- 69 4.8 SINGULARITY AND OTHER CONCERNS ---- 72 4.8.1 SUPERINTELLIGENCE AND SINGULARITY 72 4.8.2 OTHER CONCERNS ----- 75 REFERENCES - 76 CHAPTER 5 AL IN LIFE: FROM CRADLE TO GRAVE ---- 82 5.1 PREGNANCY AND POST-DELIVERY -----83 5.1.1 INFERTILITY TREATMENT -----83 CONTENTS - XIII 5.1.2 5.1.3 5.2 5.3 5.4 5.5 5.5.1 5.5.2 SPERM AND EMBRYO CULTURING ---- 86 PREGNANT WOMAN SUPPORT - 87 OBSTETRICS AND GYNECOLOGY (OB/GYN) ---- 88 PEDIATRICS ---- 90 DAILY LIFE - 92 NCDS AND FRAILTY ---- 93 NCDS -----94 FRAILTY ---- 95 REFERENCES ---- 98 CHAPTER 6 AL IN QOL (QUALITY OF LIVING), QOS (QUALITY OF SLEEPING), AND QOD (QUALITY OF DYING) ---- 101 6.1 6.1.1 6.1.2 6.2 6.2.1 6.2.2 6.2.3 6.2.4 6.3 QUALITY OF LIVING (QOL) ---- 101 QOL BY GENERAL HEALTHCARE ---- 103 QOL BY CHECKING EXCRETIONS/SECRETIONS ---- 104 QUALITY OF SLEEP (QOS) ---- 107 CHECKING QUALITY OF SLEEP ---- 108 HEADBAND ---- 109 ARMBAND ---- 109 BED AND MATTRESS ---- 109 QUALITY OF DYING (QOD) ---- 110 REFERENCES ---- 114 CHAPTER? AL IN FOOD INDUSTRY ---- 118 7.1 7.1.1 7.1.2 7.2 7.2.1 7.2.2 7.3 7.3.1 7.3.2 7.3.3 7.3.4 7.4 7.4.1 7.4.2 7.5 FOOD INDUSTRY AND BIODIVERSITY ---- 118 FOOD INDUSTRY ---- 118 BIODIVERSITY ---- 119 AGRICULTURE INDUSTRY ---- 120 OUTDOOR FIELD AGRICULTURE ---- 120 INDOOR VEGETABLE FACTORY ---- 122 ANIMAL HUSBANDRY ---- 124 LIVESTOCK INDUSTRY ---- 128 DAIRY INDUSTRY ---- 128 POULTRY INDUSTRY ---- 129 GIBIER ---- 131 MARINE PRODUCTS INDUSTRY ---- 132 NATURAL OCEAN FISH CATCHING ---- 132 AQUACULTURE ---- 133 SUPPLY MECHANISM AND DRONE DELIVERY ---- 136 XIV CONTENTS 7.6 FUNCTIONAL FOODS ---- 137 7.7 FOOD SAFETY AND WASTE ----- 140 7.8 AL-SUPPORTED FOOD TECHNOLOGY ---- 142 7.9 YOU ARE WHAT YOU EAT ----- 143 REFERENCES ---- 146 COFFEE BREAK: INFORMATION DIABETES - 153 REFERENCES ---- 156 CHAPTER 8 AL IN PRACTICE OF MEDICINE - 158 8.1 INTRODUCTION ---- 158 8.2 AL MEDICINE VERSUS ES MEDICINE ----- 162 8.3 PREVENTIVE MEDICINE ---- 164 8.3.1 PREVENTION ---- 164 8.3.2 PREDICTION ----- 168 8.4 DIAGNOSIS ----- 169 8.4.1 INTRODUCTION ---- 169 8.4.2 DIAGNOSIS ----- 171 8.4.3 DIAGNOSIS CASES ---- 174 8.4.4 AL DIAGNOSIS VERSUS DOCTOR DIAGNOSIS ---- 211 8.4.5 IATROGENESIS ---- 217 8.5 TRIAGE ---- 217 8.5.1 TRIAGE IN GENERAL ---- 217 8.5.2 TRIAGE IN COVID-19 ERA ---- 222 8.6 TREATMENT, PRECISION MEDICINE, PAIN MANAGEMENT ---- 223 8.6.1 TREATMENT CASES ---- 223 8.6.2 PRECISION MEDICINE AND EDGE-AI ----- 238 8.6.3 PAIN MANAGEMENT ---- 244 8.6.4 ALLERGY ---- 253 8.6.5 DRUG DEVELOPMENT ---- 256 8.6.6 MEDICAL CARE OPERATIONS ---- 256 8.6.7 SURGICAL ROBOT TECHNOLOGIES ------- 261 8.7 PROGNOSIS ---- 264 8.7.1 DIAGNOSIS AND PROGNOSIS ----- 264 8.7.2 REMAINING LIFE PREDICTION ----- 267 8.8 SPORTS MEDICINE ---- 271 8.9 COSMETIC SURGERY ---- 273 8.10 CONCERNS AND FUTURE ---- 274 8.10.1 CONCERNS ---- 275 8.10.2 FUTURE ---- 277 REFERENCES ---- 277 CONTENTS - YY XV CHAPTER 9 AL IN PRACTICE OF DENTISTRY - 302 9.1 DENTISTRY VERSUS MEDICINE ----- 302 9.2 AL DENTISTRY ----- 304 9.2.1 DIGITAL DENTISTRY ---- 304 9.2.2 HEALTH DATA MANAGEMENT ----- 305 9.2.3 AL DENTISTRY ----- 308 9.3 AL DENTAL DISCIPLINES ---- 311 9.3.1 IMPLANTOLOGY ----- 311 9.3.2 PROSTHODONTICS ----- 313 9.3.3 ORTHODONTICS ----- 314 9.3.4 PERIODONTICS ----- 322 9.3.5 ENDODONTICS ----- 323 9.3.6 PEDIATRIC DENTISTRY ---- 324 9.3.7 ORAL CANCERS ----- 325 9.3.8 RADIOLOGY ----- 325 9.4 AL DENTAL LABORATORY AND TECHNICIANS ---- 328 9.5 CLINICAL RECORDING AND DATA SECURITY ---- 330 9.5.1 SOAP ---- 330 9.5.2 POS/POMR---- 332 9.5.3 PKC ---- 333 9.5.4 HIPAA ---- 334 9.6 ADVANCED DENTISTRY IN FUTURE ---- 336 9.6.1 DENTISTRY IN GENERAL ---- 336 9.6.2 DIGITAL DENTISTRY ---- 337 9.6.3 TELEDENTISTRY ---- 340 9.6.4 SYSTEMIC TREATMENT ---- 342 REFERENCES ---- 346 CHAPTER 10 AL IN DRUG DEVELOPMENT - 356 10.1 AL-ASSISTED NEW DRUG DEVELOPMENT ---- 357 10.1.1 DRUG DESIGN ---- 358 10.1.2 TARGET IDENTIFICATION ---- 360 10.1.3 LEAD COMPOUND IDENTIFICATION ---- 362 10.1.4 CLINICAL RESEARCH ---- 364 10.1.5 OVERALL ---- 366 10.1.6 COVID-19 VACCINE DEVELOPMENT ----- 368 10.1.7 FUTURE ACTIVITIES ---- 370 10.2 AL-INCORPORATED DRUG DELIVERY SYSTEMS ---- 374 10.3 SIDE EFFECT AND DRUG REPOSITIONING ---- 376 XVI - CONTENTS 10.3.1 SIDE EFFECT AND ITS PREDICTION ---- 376 10.3.2 DRUG REPOSITIONING ---- 380 10.3.3 BIOSIMILAR AND GENERIC DRUGS ----- 383 10.4 DRUG INFORMATION MANAGEMENT AND PHARMACIST ---- 385 10.4.1 DRUG INFORMATION MANAGEMENT ----- 385 10.4.2 PRESCRIPTION ERRORS AND MANAGEMENT ---- 386 10.4.3 ROLE OF PHARMACISTS ------- 389 10.5 PLACEBO EFFECT AND NOCEBO EFFECT ----- 390 10.5.1 PLACEBO EFFECT ----- 390 10.5.2 NOCEBO EFFECT ----- 393 REFERENCES ---- 395 CHAPTER 11 AL IN MATERIALS SCIENCE AND DEVELOPMENT - 402 11.1 AL-ASSISTED MATERIALS SCIENCE ----- 402 11.2 SMART MATERIALS ---- 404 11.3 AL-ASSISTED MATERIALS DESIGN AND DEVELOPMENT ----- 405 REFERENCES - 411 CHAPTER 12 AL IN COVID-19 ERA, INFODEMIC, AND POST-COVID-19 ERA ---- 414 12.1 WITH COVID-19 ---- 414 12.2 SOME CONCERNS AND INFODEMIC ---- 420 12.2.1 CONCERNS ---- 420 12.2.2 INFODEMIC ---- 422 12.3 POST COVID-19 ----- 424 REFERENCES ---- 428 CHAPTER 13 AL IN FUTURE ---- 431 13.1 PRESENT AND FUTURE OF AL TECHNOLOGY ---- 432 13.1.1 REINFORCEMENT LEARNING (RL) ---- 432 13.1.2 GENERATIVE ADVERSARIAL NETWORKS (GAN) ---- 436 13.1.3 DRASTIC CHANGE IN EMPLOYMENT SECTOR AND SOCIETY ---- 439 13.1.4 AUTOMATED TRANSPORTATION ----- 440 13.2 ECOSYSTEM ---- 442 13.3 BIOINFORMATICS AND ALIFE ----- 443 13.3.1 BIOINFORMATICS ---- 443 13.3.2 ALIFE ---- 446 13.4 MEDICINE ---- 447 13.4.1 VOLUMETRIC DISPLAY TECHNOLOGY ---- 447 13.4.2 PARITY MIRROR IMAGING ----- 450 CONTENTS - XVII 13.5 BRAIN-COMPUTER INTERFACE (BCI) - 451 13.5.1 CONSCIOUSNESS OF ROBOT ---- 451 13.5.2 HUMAN-ROBOT INTERACTION ---- 454 13.6 PREDICTION AND SINGULARITY - 457 13.6.1 PREDICTION BEFORE SINGULARITY ---- 457 13.6.2 SINGULARITY AND BEYOND ---- 462 13.7 QUANTUM COMPUTERS ---- 463 REFERENCES - 465 CLOSING REMARKS ---- 472 REFERENCES ---- 473 INDEX ---- 475 Contents Preface — V List of abbreviations — XIX About the Author-----XXIX Chapter 1 Al in general---- 1 1.1 Undefined definition---- 1 1.2 History of Al development and future---- 2 1.3 Nature-----5 1.3.1 Ingenerai----- 5 1.3.2 As a part of IT----- 7 1.4 Classification----- 8 1.4.1 Elemental technologies involved in Al----- 8 1.4.2 Three Als----- 11 1.5 Role, function, and applications of Al----- 13 1.5.1 Role---- 13 1.5.2 Function----- 14 1.5.3 Supporting technologies---- 14 1.5.4 Applications----- 17 1.6 Advantages and disadvantages —18 1.6.1 Advantages----- 18 1.6.2 Disadvantages---- 18 References-----19 Chapter 2 Al in information---- 23 2.1 Data versus information---- 23 2.1.1 Data---- 24 2.1.2 Data mining, information, and DIKW hierarchy 2.2 Knowledge, intelligence, and intellect---- 26 2.3 Al ontology-----29 References-----30 Chapter 3 Al in society---- 32 3.1 Global-----32 3.2 Societal---35 ХИ — 3.3 3.3.1 3.3.2 3.3.3 3.3.4 3.3.5 3.4 Contents Personal----- 37 Technological environment----- 37 Examples of jobs that are likely to be substituted by Al Representative examples of less likely positions to be substituted by Al---- 40 New-type jobs that Al creates----- 41 Work-style reformation-----42 Future of Al society----- 43 References---- 44 Chapter 4 Al in concern---- 47 Digital clone---- 47 4.1 Personality-----49 4.2 Legal personality---- 49 4.2.1 Personality---- 50 4.2.2 Consciousness, gender, and marriage-----50 4.2.3 IQ and common sense---- 52 4.3 IQ test---- 52 4.3.1 Common sense-----54 4.3.2 4.3.3 Lie and Sontaku-----55 4.4 Bias and errors-----57 4.4.1 Bias-----57 4.4.2 Errors---- 58 4.4.3 Computer virus and immune system-----60 4.5 EQ and ethics---- 61 4.5.1 EQ---- 62 4.5.2 Ethics---- 63 4.5.3 Accountability---- 65 4.6 Privacy and its related issues-----67 4.6.1 Privacy---- 67 4.6.2 Transparency and explainability-----68 4.7 Copyright-----69 4.8 Singularity and other concerns-----72 4.8.1 Superintelligent and singularity-----72 4.8.2 Other concerns-----75 References-----76 Chapter 5 Al in life: from cradle to grave---- 82 5-1 Pregnancy and post-delivery----- 83 5.1.1 Infertility treatment------83 Contents 5.1.2 5.1.3 5.2 5.3 5.4 5.5 5.5.1 5.5.2 Sperm and embryo culturing---- 86 Pregnant woman support-----87 Obstetrics and gynecology (OB/GYN)-----88 Pediatrics---- 90 Daily life---- 92 NCDs and frailty---- 93 NCDs---- 94 Frailty---- 95 References---- 98 Chapter 6 Al in QOL (quality of living), QOS (quality of sleeping), and QOD (quality of dying)---- 101 6.1 Quality of living (QOL)---- 101 6.1.1 QOL by general healthcare---- 103 6.1.2 QOL by checking excretions/secretions---- 104 6.2 Quality of sleep (QOS)----- 107 6.2.1 Checking quality of sleep---- 108 6.2.2 Headband---- 109 6.2.3 Armband---- 109 6.2.4 Bed and mattress---- 109 6.3 Quality of dying (QOD)------ 110 References---- 114 Chapter 7 Al in food industry---- 118 7.1 Food industry and biodiversity-----118 7.1.1 Food industry----- 118 7.1.2 Biodiversity----- 119 7.2 Agriculture industry---- 120 7.2.1 Outdoor field agriculture----- 120 7.2.2 Indoor vegetable factory----- 122 7.3 Animal husbandry----- 124 7.3.1 Livestock industry---- 128 7.3.2 Dairy industry----- 128 7.3.3 Poultry industry---- 129 7.3.4 Gibier---- 131 7.4 Marine products industry---- 132 7.4.1 Natural ocean fish catching---- 132 7.4.2 Aquaculture----- 133 7.5 Supply mechanism and drone delivery---- 136 XIII XIV ----- 7.6 7.7 7.8 7.9 Contents Functional foods-—137 Food safety and waste —■ 140 Al-supported food technology------142 You are what you eat-----143 References---- 146 Coffee break: information diabetes----- 153 References---- 156 Chapter 8 Al in practice of medicine----- 158 8.1 8.2 8.3 8.3.1 8.3.2 8.4 8.4.1 8.4.2 8.4.3 8.4.4 8.4.5 8.5 8.5.1 8.5.2 8.6 8.6.1 8.6.2 8.6.3 8.6.4 8.6.5 8.6.6 8.6.7 8.7 8.7.1 8.7.2 8.8 8.9 8.10 8.10.1 8.10.2 Introduction-----158 Al medicine versus ES medicine-----162 Preventive medicine------ 164 Prevention---- 164 Prediction-----168 Diagnosis----- 169 Introduction-----169 Diagnosis----- 171 Diagnosis cases---- 174 Al diagnosis versus doctor diagnosis-----211 Iatrogenesis---- 217 Triage-----217 Triage in general---- 217 Triage in COVID-19 era----- 222 Treatment, precision medicine, pain management-----223 Treatment cases---- 223 Precision medicineand Edge-AI------238 Pain management-244 Allergy----- 253 Drug development----- 256 Medical care operations----- 256 Surgical robot technologies---- 261 Prognosis-----264 Diagnosis and prognosis------264 Remaining life prediction---- 267 Sports medicine----- 271 Cosmetic surgery-----273 Concerns and future----- 274 Concerns---- 275 Future----- 277 References-----277 Chapter 9 Al in practice of dentistry----- 302 9.1 9.2 Dentistry versus medicine----- 302 Al dentistry----- 304 9.2.1 Digital dentistry----- 304 9.2.2 Health data management----- 305 9.2.3 Al dentistry------ 308 9.3 9.3.1 Al dental disciplines----- 311 Implantology------ 311 9.3.2 Prosthodontics----- 313 9.3.3 Orthodontics------ 314 9.3.4 Periodontics------322 9.3.5 Endodontics------ 323 9.3.6 Pediatric dentistry----- 324 9.3.7 Oral cancers------ 325 9.3.8 Radiology----- 325 9.4 Al dental laboratory and technicians----- 328 9.5 9.5.1 Clinical recording and data security----- 330 SOAP----- 330 9.5.2 POS/POMR------ 332 9.5.3 PKC----- 333 9.5.4 HIPAA----- 334 9.6 Advanced dentistry in future----- 336 9.6.1 Dentistry in general — 336 9.6.2 Digital dentistry----- 337 9.6.3 Teledentistry------ 340 9.6.4 Systemic treatment----- 342 References----- 346 Chapter 10 Al in drug development — 356 10.1 Al-assisted new drug development----- 357 10.1.1 Drug design----- 358 10.1.2 Target identification — 360 10.1.3 Lead compound identification----- 362 10.1.4 Clinical research----- 364 10.1.5 Overall----- 366 10.1.6 10.1.7 COVID-19 vaccine development----- 368 Future activities----- 370 10.2 Al-incorporated drug delivery systems-----374 10.3 Side effect and drug repositioning----- 376 XVI ---- 10.3.1 10.3.2 10.3.3 10.4 10.4.1 10.4.2 10.4.3 10.5 10.5.1 10.5.2 Contents Side effect and its prediction----- 376 Drug repositioning---- 380 Biosimilar and generic drugs----- 383 Drug information management and pharmacist Drug information management-----385 Prescription errors and management-----386 Role of pharmacists---- 389 Placebo effect and nocebo effect-----390 Placebo effect---- 390 Nocebo effect---- 393 References---- 395 385 Chapter 11 Al in materials science and development-----402 11.1 Al-assisted materials science---- 402 11.2 Smart materials-----404 11.3 Al-assisted materials design and development------ 405 References-----411 Chapter 12 Al in COVID -19 era, infodemic, and post-COVID-19 era 12.1 With COVID-19---- 414 12.2 Some concerns and infodemic-----420 12.2.1 Concerns---- 420 12.2.2 Infodemic---- 422 12.3 Post COVID-19---- 424 References---- 428 Chapter 13 Al in future ---- 431 13.1 Present and future of Al technology-----432 13.1.1 Reinforcement learning (RL)-----432 13.1.2 Generative adversarial networks (GAN)-----436 13.1.3 Drastic change in employment sector and society-----439 13.1.4 Automated transportation---- 440 13.2 Ecosystem---- 442 13.3 Bioinformatics and ALife-----443 13.3.1 Bioinformatics---- 443 13.3.2 ALife---- 446 13.4 Medicine-----447 13.4.1 Volumetric display technology---- 447 13.4.2 Parity mirror imaging---- 450 Contents 13.5 13.5.1 13.5.2 13.6 13.6.1 13.6.2 13.7 Brain-computer interface (ВСІ)-----451 Consciousness of robot------451 Human-robot interaction------454 Prediction and singularity------457 Prediction before singularity-----457 Singularity and beyond------462 Quantum computers-----463 References-----465 Closing remarks----- 472 References-----473 Index----- 475 — XVII
adam_txt	CONTENTS PREFACE - V LIST OF ABBREVIATIONS - XIX ABOUT THE AUTHOR ---- XXIX CHAPTER 1 AL IN GENERAL - 1 1.1 1.2 1.3 1.3.1 1.3.2 1.4 1.4.1 1.4.2 1.5 1.5.1 1.5.2 1.5.3 1.5.4 1.6 1.6.1 1.6.2 UNDEFINED DEFINITION - 1 HISTORY OF AL DEVELOPMENT AND FUTURE ---- 2 NATURE ---- 5 IN GENERAL - 5 AS A PART OF IT ---- 7 CLASSIFICATION - 8 ELEMENTAL TECHNOLOGIES INVOLVED IN AL -----8 THREE ALS ---- 11 ROLE, FUNCTION, AND APPLICATIONS OF AL ---- 13 ROLE ---- 13 FUNCTION - 14 SUPPORTING TECHNOLOGIES ---- 14 APPLICATIONS ---- 17 ADVANTAGES AND DISADVANTAGES ---- 18 ADVANTAGES ---- 18 DISADVANTAGES ---- 18 REFERENCES ---- 19 CHAPTER 2 AL IN INFORMATION ---- 23 2.1 2.1.1 2.1.2 2.2 2.3 DATA VERSUS INFORMATION ---- 23 DATA ---- 24 DATA MINING, INFORMATION, AND DIKW HIERARCHY ---- 25 KNOWLEDGE, INTELLIGENCE, AND INTELLECT ---- 26 AL ONTOLOGY ---- 29 REFERENCES ---- 30 CHAPTER 3 AL IN SOCIETY ---- 32 3.1 3.2 GLOBAL ---- 32 SOCIETAL ---- 35 XII - CONTENTS 3.3 PERSONAL ----- 37 3.3.1 TECHNOLOGICAL ENVIRONMENT --- 37 3.3.2 EXAMPLES OF JOBS THAT ARE LIKELY TO BE SUBSTITUTED BY AL ---- 39 3.3.3 REPRESENTATIVE EXAMPLES OF LESS LIKELY POSITIONS TO BE SUBSTITUTED BY AL ---- 40 3.3.4 NEW-TYPE JOBS THAT AL CREATES ----- 41 3.3.5 WORK-STYLE REFORMATION -----42 3.4 FUTURE OF AL SOCIETY ----- 43 REFERENCES ---- 44 CHAPTER 4 AL IN CONCERN - 47 4.1 DIGITAL CLONE ---- 47 4.2 PERSONALITY ---- 49 4.2.1 LEGAL PERSONALITY ----- 49 4.2.2 PERSONALITY ---- 50 4.2.3 CONSCIOUSNESS, GENDER, AND MARRIAGE ---- 50 4.3 IQ AND COMMON SENSE ---- 52 4.3.1 IQ TEST ---- 52 4.3.2 COMMON SENSE ----- 54 4.3.3 LIE AND SONTAKU ----- 55 4.4 BIAS AND ERRORS ----- 57 4.4.1 BIAS ---- 57 4.4.2 ERRORS ---- 58 4.4.3 COMPUTER VIRUS AND IMMUNE SYSTEM ---- 60 4.5 EQ AND ETHICS ----- 61 4.5.1 EQ---- 62 4.5.2 ETHICS ---- 63 4.5.3 ACCOUNTABILITY ----- 65 4.6 PRIVACY AND ITS RELATED ISSUES ---- 67 4.6.1 PRIVACY ---- 67 4.6.2 TRANSPARENCY AND EXPLAINABILITY 68 4.7 COPYRIGHT ---- 69 4.8 SINGULARITY AND OTHER CONCERNS ---- 72 4.8.1 SUPERINTELLIGENCE AND SINGULARITY 72 4.8.2 OTHER CONCERNS ----- 75 REFERENCES - 76 CHAPTER 5 AL IN LIFE: FROM CRADLE TO GRAVE ---- 82 5.1 PREGNANCY AND POST-DELIVERY -----83 5.1.1 INFERTILITY TREATMENT -----83 CONTENTS - XIII 5.1.2 5.1.3 5.2 5.3 5.4 5.5 5.5.1 5.5.2 SPERM AND EMBRYO CULTURING ---- 86 PREGNANT WOMAN SUPPORT - 87 OBSTETRICS AND GYNECOLOGY (OB/GYN) ---- 88 PEDIATRICS ---- 90 DAILY LIFE - 92 NCDS AND FRAILTY ---- 93 NCDS -----94 FRAILTY ---- 95 REFERENCES ---- 98 CHAPTER 6 AL IN QOL (QUALITY OF LIVING), QOS (QUALITY OF SLEEPING), AND QOD (QUALITY OF DYING) ---- 101 6.1 6.1.1 6.1.2 6.2 6.2.1 6.2.2 6.2.3 6.2.4 6.3 QUALITY OF LIVING (QOL) ---- 101 QOL BY GENERAL HEALTHCARE ---- 103 QOL BY CHECKING EXCRETIONS/SECRETIONS ---- 104 QUALITY OF SLEEP (QOS) ---- 107 CHECKING QUALITY OF SLEEP ---- 108 HEADBAND ---- 109 ARMBAND ---- 109 BED AND MATTRESS ---- 109 QUALITY OF DYING (QOD) ---- 110 REFERENCES ---- 114 CHAPTER? AL IN FOOD INDUSTRY ---- 118 7.1 7.1.1 7.1.2 7.2 7.2.1 7.2.2 7.3 7.3.1 7.3.2 7.3.3 7.3.4 7.4 7.4.1 7.4.2 7.5 FOOD INDUSTRY AND BIODIVERSITY ---- 118 FOOD INDUSTRY ---- 118 BIODIVERSITY ---- 119 AGRICULTURE INDUSTRY ---- 120 OUTDOOR FIELD AGRICULTURE ---- 120 INDOOR VEGETABLE FACTORY ---- 122 ANIMAL HUSBANDRY ---- 124 LIVESTOCK INDUSTRY ---- 128 DAIRY INDUSTRY ---- 128 POULTRY INDUSTRY ---- 129 GIBIER ---- 131 MARINE PRODUCTS INDUSTRY ---- 132 NATURAL OCEAN FISH CATCHING ---- 132 AQUACULTURE ---- 133 SUPPLY MECHANISM AND DRONE DELIVERY ---- 136 XIV CONTENTS 7.6 FUNCTIONAL FOODS ---- 137 7.7 FOOD SAFETY AND WASTE ----- 140 7.8 AL-SUPPORTED FOOD TECHNOLOGY ---- 142 7.9 YOU ARE WHAT YOU EAT ----- 143 REFERENCES ---- 146 COFFEE BREAK: INFORMATION DIABETES - 153 REFERENCES ---- 156 CHAPTER 8 AL IN PRACTICE OF MEDICINE - 158 8.1 INTRODUCTION ---- 158 8.2 AL MEDICINE VERSUS ES MEDICINE ----- 162 8.3 PREVENTIVE MEDICINE ---- 164 8.3.1 PREVENTION ---- 164 8.3.2 PREDICTION ----- 168 8.4 DIAGNOSIS ----- 169 8.4.1 INTRODUCTION ---- 169 8.4.2 DIAGNOSIS ----- 171 8.4.3 DIAGNOSIS CASES ---- 174 8.4.4 AL DIAGNOSIS VERSUS DOCTOR DIAGNOSIS ---- 211 8.4.5 IATROGENESIS ---- 217 8.5 TRIAGE ---- 217 8.5.1 TRIAGE IN GENERAL ---- 217 8.5.2 TRIAGE IN COVID-19 ERA ---- 222 8.6 TREATMENT, PRECISION MEDICINE, PAIN MANAGEMENT ---- 223 8.6.1 TREATMENT CASES ---- 223 8.6.2 PRECISION MEDICINE AND EDGE-AI ----- 238 8.6.3 PAIN MANAGEMENT ---- 244 8.6.4 ALLERGY ---- 253 8.6.5 DRUG DEVELOPMENT ---- 256 8.6.6 MEDICAL CARE OPERATIONS ---- 256 8.6.7 SURGICAL ROBOT TECHNOLOGIES ------- 261 8.7 PROGNOSIS ---- 264 8.7.1 DIAGNOSIS AND PROGNOSIS ----- 264 8.7.2 REMAINING LIFE PREDICTION ----- 267 8.8 SPORTS MEDICINE ---- 271 8.9 COSMETIC SURGERY ---- 273 8.10 CONCERNS AND FUTURE ---- 274 8.10.1 CONCERNS ---- 275 8.10.2 FUTURE ---- 277 REFERENCES ---- 277 CONTENTS - YY XV CHAPTER 9 AL IN PRACTICE OF DENTISTRY - 302 9.1 DENTISTRY VERSUS MEDICINE ----- 302 9.2 AL DENTISTRY ----- 304 9.2.1 DIGITAL DENTISTRY ---- 304 9.2.2 HEALTH DATA MANAGEMENT ----- 305 9.2.3 AL DENTISTRY ----- 308 9.3 AL DENTAL DISCIPLINES ---- 311 9.3.1 IMPLANTOLOGY ----- 311 9.3.2 PROSTHODONTICS ----- 313 9.3.3 ORTHODONTICS ----- 314 9.3.4 PERIODONTICS ----- 322 9.3.5 ENDODONTICS ----- 323 9.3.6 PEDIATRIC DENTISTRY ---- 324 9.3.7 ORAL CANCERS ----- 325 9.3.8 RADIOLOGY ----- 325 9.4 AL DENTAL LABORATORY AND TECHNICIANS ---- 328 9.5 CLINICAL RECORDING AND DATA SECURITY ---- 330 9.5.1 SOAP ---- 330 9.5.2 POS/POMR---- 332 9.5.3 PKC ---- 333 9.5.4 HIPAA ---- 334 9.6 ADVANCED DENTISTRY IN FUTURE ---- 336 9.6.1 DENTISTRY IN GENERAL ---- 336 9.6.2 DIGITAL DENTISTRY ---- 337 9.6.3 TELEDENTISTRY ---- 340 9.6.4 SYSTEMIC TREATMENT ---- 342 REFERENCES ---- 346 CHAPTER 10 AL IN DRUG DEVELOPMENT - 356 10.1 AL-ASSISTED NEW DRUG DEVELOPMENT ---- 357 10.1.1 DRUG DESIGN ---- 358 10.1.2 TARGET IDENTIFICATION ---- 360 10.1.3 LEAD COMPOUND IDENTIFICATION ---- 362 10.1.4 CLINICAL RESEARCH ---- 364 10.1.5 OVERALL ---- 366 10.1.6 COVID-19 VACCINE DEVELOPMENT ----- 368 10.1.7 FUTURE ACTIVITIES ---- 370 10.2 AL-INCORPORATED DRUG DELIVERY SYSTEMS ---- 374 10.3 SIDE EFFECT AND DRUG REPOSITIONING ---- 376 XVI - CONTENTS 10.3.1 SIDE EFFECT AND ITS PREDICTION ---- 376 10.3.2 DRUG REPOSITIONING ---- 380 10.3.3 BIOSIMILAR AND GENERIC DRUGS ----- 383 10.4 DRUG INFORMATION MANAGEMENT AND PHARMACIST ---- 385 10.4.1 DRUG INFORMATION MANAGEMENT ----- 385 10.4.2 PRESCRIPTION ERRORS AND MANAGEMENT ---- 386 10.4.3 ROLE OF PHARMACISTS ------- 389 10.5 PLACEBO EFFECT AND NOCEBO EFFECT ----- 390 10.5.1 PLACEBO EFFECT ----- 390 10.5.2 NOCEBO EFFECT ----- 393 REFERENCES ---- 395 CHAPTER 11 AL IN MATERIALS SCIENCE AND DEVELOPMENT - 402 11.1 AL-ASSISTED MATERIALS SCIENCE ----- 402 11.2 SMART MATERIALS ---- 404 11.3 AL-ASSISTED MATERIALS DESIGN AND DEVELOPMENT ----- 405 REFERENCES - 411 CHAPTER 12 AL IN COVID-19 ERA, INFODEMIC, AND POST-COVID-19 ERA ---- 414 12.1 WITH COVID-19 ---- 414 12.2 SOME CONCERNS AND INFODEMIC ---- 420 12.2.1 CONCERNS ---- 420 12.2.2 INFODEMIC ---- 422 12.3 POST COVID-19 ----- 424 REFERENCES ---- 428 CHAPTER 13 AL IN FUTURE ---- 431 13.1 PRESENT AND FUTURE OF AL TECHNOLOGY ---- 432 13.1.1 REINFORCEMENT LEARNING (RL) ---- 432 13.1.2 GENERATIVE ADVERSARIAL NETWORKS (GAN) ---- 436 13.1.3 DRASTIC CHANGE IN EMPLOYMENT SECTOR AND SOCIETY ---- 439 13.1.4 AUTOMATED TRANSPORTATION ----- 440 13.2 ECOSYSTEM ---- 442 13.3 BIOINFORMATICS AND ALIFE ----- 443 13.3.1 BIOINFORMATICS ---- 443 13.3.2 ALIFE ---- 446 13.4 MEDICINE ---- 447 13.4.1 VOLUMETRIC DISPLAY TECHNOLOGY ---- 447 13.4.2 PARITY MIRROR IMAGING ----- 450 CONTENTS - XVII 13.5 BRAIN-COMPUTER INTERFACE (BCI) - 451 13.5.1 CONSCIOUSNESS OF ROBOT ---- 451 13.5.2 HUMAN-ROBOT INTERACTION ---- 454 13.6 PREDICTION AND SINGULARITY - 457 13.6.1 PREDICTION BEFORE SINGULARITY ---- 457 13.6.2 SINGULARITY AND BEYOND ---- 462 13.7 QUANTUM COMPUTERS ---- 463 REFERENCES - 465 CLOSING REMARKS ---- 472 REFERENCES ---- 473 INDEX ---- 475 Contents Preface — V List of abbreviations — XIX About the Author-----XXIX Chapter 1 Al in general---- 1 1.1 Undefined definition---- 1 1.2 History of Al development and future---- 2 1.3 Nature-----5 1.3.1 Ingenerai----- 5 1.3.2 As a part of IT----- 7 1.4 Classification----- 8 1.4.1 Elemental technologies involved in Al----- 8 1.4.2 Three Als----- 11 1.5 Role, function, and applications of Al----- 13 1.5.1 Role---- 13 1.5.2 Function----- 14 1.5.3 Supporting technologies---- 14 1.5.4 Applications----- 17 1.6 Advantages and disadvantages —18 1.6.1 Advantages----- 18 1.6.2 Disadvantages---- 18 References-----19 Chapter 2 Al in information---- 23 2.1 Data versus information---- 23 2.1.1 Data---- 24 2.1.2 Data mining, information, and DIKW hierarchy 2.2 Knowledge, intelligence, and intellect---- 26 2.3 Al ontology-----29 References-----30 Chapter 3 Al in society---- 32 3.1 Global-----32 3.2 Societal---35 ХИ — 3.3 3.3.1 3.3.2 3.3.3 3.3.4 3.3.5 3.4 Contents Personal----- 37 Technological environment----- 37 Examples of jobs that are likely to be substituted by Al Representative examples of less likely positions to be substituted by Al---- 40 New-type jobs that Al creates----- 41 Work-style reformation-----42 Future of Al society----- 43 References---- 44 Chapter 4 Al in concern---- 47 Digital clone---- 47 4.1 Personality-----49 4.2 Legal personality---- 49 4.2.1 Personality---- 50 4.2.2 Consciousness, gender, and marriage-----50 4.2.3 IQ and common sense---- 52 4.3 IQ test---- 52 4.3.1 Common sense-----54 4.3.2 4.3.3 Lie and Sontaku-----55 4.4 Bias and errors-----57 4.4.1 Bias-----57 4.4.2 Errors---- 58 4.4.3 Computer virus and immune system-----60 4.5 EQ and ethics---- 61 4.5.1 EQ---- 62 4.5.2 Ethics---- 63 4.5.3 Accountability---- 65 4.6 Privacy and its related issues-----67 4.6.1 Privacy---- 67 4.6.2 Transparency and explainability-----68 4.7 Copyright-----69 4.8 Singularity and other concerns-----72 4.8.1 Superintelligent and singularity-----72 4.8.2 Other concerns-----75 References-----76 Chapter 5 Al in life: from cradle to grave---- 82 5-1 Pregnancy and post-delivery----- 83 5.1.1 Infertility treatment------83 Contents 5.1.2 5.1.3 5.2 5.3 5.4 5.5 5.5.1 5.5.2 Sperm and embryo culturing---- 86 Pregnant woman support-----87 Obstetrics and gynecology (OB/GYN)-----88 Pediatrics---- 90 Daily life---- 92 NCDs and frailty---- 93 NCDs---- 94 Frailty---- 95 References---- 98 Chapter 6 Al in QOL (quality of living), QOS (quality of sleeping), and QOD (quality of dying)---- 101 6.1 Quality of living (QOL)---- 101 6.1.1 QOL by general healthcare---- 103 6.1.2 QOL by checking excretions/secretions---- 104 6.2 Quality of sleep (QOS)----- 107 6.2.1 Checking quality of sleep---- 108 6.2.2 Headband---- 109 6.2.3 Armband---- 109 6.2.4 Bed and mattress---- 109 6.3 Quality of dying (QOD)------ 110 References---- 114 Chapter 7 Al in food industry---- 118 7.1 Food industry and biodiversity-----118 7.1.1 Food industry----- 118 7.1.2 Biodiversity----- 119 7.2 Agriculture industry---- 120 7.2.1 Outdoor field agriculture----- 120 7.2.2 Indoor vegetable factory----- 122 7.3 Animal husbandry----- 124 7.3.1 Livestock industry---- 128 7.3.2 Dairy industry----- 128 7.3.3 Poultry industry---- 129 7.3.4 Gibier---- 131 7.4 Marine products industry---- 132 7.4.1 Natural ocean fish catching---- 132 7.4.2 Aquaculture----- 133 7.5 Supply mechanism and drone delivery---- 136 XIII XIV ----- 7.6 7.7 7.8 7.9 Contents Functional foods-—137 Food safety and waste —■ 140 Al-supported food technology------142 You are what you eat-----143 References---- 146 Coffee break: information diabetes----- 153 References---- 156 Chapter 8 Al in practice of medicine----- 158 8.1 8.2 8.3 8.3.1 8.3.2 8.4 8.4.1 8.4.2 8.4.3 8.4.4 8.4.5 8.5 8.5.1 8.5.2 8.6 8.6.1 8.6.2 8.6.3 8.6.4 8.6.5 8.6.6 8.6.7 8.7 8.7.1 8.7.2 8.8 8.9 8.10 8.10.1 8.10.2 Introduction-----158 Al medicine versus ES medicine-----162 Preventive medicine------ 164 Prevention---- 164 Prediction-----168 Diagnosis----- 169 Introduction-----169 Diagnosis----- 171 Diagnosis cases---- 174 Al diagnosis versus doctor diagnosis-----211 Iatrogenesis---- 217 Triage-----217 Triage in general---- 217 Triage in COVID-19 era----- 222 Treatment, precision medicine, pain management-----223 Treatment cases---- 223 Precision medicineand Edge-AI------238 Pain management-244 Allergy----- 253 Drug development----- 256 Medical care operations----- 256 Surgical robot technologies---- 261 Prognosis-----264 Diagnosis and prognosis------264 Remaining life prediction---- 267 Sports medicine----- 271 Cosmetic surgery-----273 Concerns and future----- 274 Concerns---- 275 Future----- 277 References-----277 Chapter 9 Al in practice of dentistry----- 302 9.1 9.2 Dentistry versus medicine----- 302 Al dentistry----- 304 9.2.1 Digital dentistry----- 304 9.2.2 Health data management----- 305 9.2.3 Al dentistry------ 308 9.3 9.3.1 Al dental disciplines----- 311 Implantology------ 311 9.3.2 Prosthodontics----- 313 9.3.3 Orthodontics------ 314 9.3.4 Periodontics------322 9.3.5 Endodontics------ 323 9.3.6 Pediatric dentistry----- 324 9.3.7 Oral cancers------ 325 9.3.8 Radiology----- 325 9.4 Al dental laboratory and technicians----- 328 9.5 9.5.1 Clinical recording and data security----- 330 SOAP----- 330 9.5.2 POS/POMR------ 332 9.5.3 PKC----- 333 9.5.4 HIPAA----- 334 9.6 Advanced dentistry in future----- 336 9.6.1 Dentistry in general — 336 9.6.2 Digital dentistry----- 337 9.6.3 Teledentistry------ 340 9.6.4 Systemic treatment----- 342 References----- 346 Chapter 10 Al in drug development — 356 10.1 Al-assisted new drug development----- 357 10.1.1 Drug design----- 358 10.1.2 Target identification — 360 10.1.3 Lead compound identification----- 362 10.1.4 Clinical research----- 364 10.1.5 Overall----- 366 10.1.6 10.1.7 COVID-19 vaccine development----- 368 Future activities----- 370 10.2 Al-incorporated drug delivery systems-----374 10.3 Side effect and drug repositioning----- 376 XVI ---- 10.3.1 10.3.2 10.3.3 10.4 10.4.1 10.4.2 10.4.3 10.5 10.5.1 10.5.2 Contents Side effect and its prediction----- 376 Drug repositioning---- 380 Biosimilar and generic drugs----- 383 Drug information management and pharmacist Drug information management-----385 Prescription errors and management-----386 Role of pharmacists---- 389 Placebo effect and nocebo effect-----390 Placebo effect---- 390 Nocebo effect---- 393 References---- 395 385 Chapter 11 Al in materials science and development-----402 11.1 Al-assisted materials science---- 402 11.2 Smart materials-----404 11.3 Al-assisted materials design and development------ 405 References-----411 Chapter 12 Al in COVID -19 era, infodemic, and post-COVID-19 era 12.1 With COVID-19---- 414 12.2 Some concerns and infodemic-----420 12.2.1 Concerns---- 420 12.2.2 Infodemic---- 422 12.3 Post COVID-19---- 424 References---- 428 Chapter 13 Al in future ---- 431 13.1 Present and future of Al technology-----432 13.1.1 Reinforcement learning (RL)-----432 13.1.2 Generative adversarial networks (GAN)-----436 13.1.3 Drastic change in employment sector and society-----439 13.1.4 Automated transportation---- 440 13.2 Ecosystem---- 442 13.3 Bioinformatics and ALife-----443 13.3.1 Bioinformatics---- 443 13.3.2 ALife---- 446 13.4 Medicine-----447 13.4.1 Volumetric display technology---- 447 13.4.2 Parity mirror imaging---- 450 Contents 13.5 13.5.1 13.5.2 13.6 13.6.1 13.6.2 13.7 Brain-computer interface (ВСІ)-----451 Consciousness of robot------451 Human-robot interaction------454 Prediction and singularity------457 Prediction before singularity-----457 Singularity and beyond------462 Quantum computers-----463 References-----465 Closing remarks----- 472 References-----473 Index----- 475 — XVII
any_adam_object	1
any_adam_object_boolean	1
author	Oshida, Yoshiki
author_GND	(DE-588)1225432790
author_facet	Oshida, Yoshiki
author_role	aut
author_sort	Oshida, Yoshiki
author_variant	y o yo
building	Verbundindex
bvnumber	BV047583848
classification_rvk	XC 4000
ctrlnum	(OCoLC)1286877087 (DE-599)DNB1226451152
discipline	Medizin
discipline_str_mv	Medizin
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a22000008c 4500</leader><controlfield tag="001">BV047583848</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20231212</controlfield><controlfield tag="007">t\|</controlfield><controlfield tag="008">211111s2022 gw a\|\|\| \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,N06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1226451152</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783110717792</subfield><subfield code="c">: EUR 86.95 (DE) (freier Preis), EUR 86.95 (AT) (freier Preis)</subfield><subfield code="9">978-3-11-071779-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3110717794</subfield><subfield code="9">3-11-071779-4</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783110717792</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1286877087</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1226451152</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-29T</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-M347</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XC 4000</subfield><subfield code="0">(DE-625)152514:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">660</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Oshida, Yoshiki</subfield><subfield code="0">(DE-588)1225432790</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Artificial intelligence for medicine</subfield><subfield code="b">people, society, pharmaceuticals, and medical materials</subfield><subfield code="c">Yoshiki Oshida</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="b">De Gruyter</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVII, 490 Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">24 cm x 17 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">De Gruyter STEM</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Künstliche Intelligenz</subfield><subfield code="0">(DE-588)4033447-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesellschaft</subfield><subfield code="0">(DE-588)4020588-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Intelligenter Werkstoff</subfield><subfield code="0">(DE-588)4274825-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Künstliche Intelligenz</subfield><subfield code="0">(DE-588)4033447-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesellschaft</subfield><subfield code="0">(DE-588)4020588-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Intelligenter Werkstoff</subfield><subfield code="0">(DE-588)4274825-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Künstliche Intelligenz</subfield><subfield code="0">(DE-588)4033447-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Walter de Gruyter GmbH & Co. KG</subfield><subfield code="0">(DE-588)10095502-2</subfield><subfield code="4">pbl</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-11-071785-3</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-11-071792-1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="u">https://www.degruyter.com/books/9783110717792</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032969182&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Augsburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032969182&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032969182</subfield></datafield></record></collection>
id	DE-604.BV047583848
illustrated	Illustrated
index_date	2024-07-03T18:34:05Z
indexdate	2024-11-27T15:01:16Z
institution	BVB
institution_GND	(DE-588)10095502-2
isbn	9783110717792 3110717794
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-032969182
oclc_num	1286877087
open_access_boolean
owner	DE-384 DE-573 DE-898 DE-BY-UBR DE-29T DE-29 DE-M347
owner_facet	DE-384 DE-573 DE-898 DE-BY-UBR DE-29T DE-29 DE-M347
physical	XXVII, 490 Seiten Illustrationen 24 cm x 17 cm
publishDate	2022
publishDateSearch	2022
publishDateSort	2022
publisher	De Gruyter
record_format	marc
series2	De Gruyter STEM
spelling	Oshida, Yoshiki (DE-588)1225432790 aut Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials Yoshiki Oshida Berlin De Gruyter [2022] XXVII, 490 Seiten Illustrationen 24 cm x 17 cm txt rdacontent n rdamedia nc rdacarrier De Gruyter STEM Künstliche Intelligenz (DE-588)4033447-8 gnd rswk-swf Medizin (DE-588)4038243-6 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Gesellschaft (DE-588)4020588-5 gnd rswk-swf Medizinische Versorgung (DE-588)4038270-9 gnd rswk-swf Intelligenter Werkstoff (DE-588)4274825-2 gnd rswk-swf Künstliche Intelligenz (DE-588)4033447-8 s Medizinische Versorgung (DE-588)4038270-9 s Gesellschaft (DE-588)4020588-5 s Arzneimittel (DE-588)4003115-9 s Intelligenter Werkstoff (DE-588)4274825-2 s DE-604 Medizin (DE-588)4038243-6 s Walter de Gruyter GmbH & Co. KG (DE-588)10095502-2 pbl Erscheint auch als Online-Ausgabe 978-3-11-071785-3 Erscheint auch als Online-Ausgabe 978-3-11-071792-1 X:MVB https://www.degruyter.com/books/9783110717792 DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032969182&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Augsburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032969182&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle	Oshida, Yoshiki Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials Künstliche Intelligenz (DE-588)4033447-8 gnd Medizin (DE-588)4038243-6 gnd Arzneimittel (DE-588)4003115-9 gnd Gesellschaft (DE-588)4020588-5 gnd Medizinische Versorgung (DE-588)4038270-9 gnd Intelligenter Werkstoff (DE-588)4274825-2 gnd
subject_GND	(DE-588)4033447-8 (DE-588)4038243-6 (DE-588)4003115-9 (DE-588)4020588-5 (DE-588)4038270-9 (DE-588)4274825-2
title	Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials
title_auth	Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials
title_exact_search	Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials
title_exact_search_txtP	Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials
title_full	Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials Yoshiki Oshida
title_fullStr	Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials Yoshiki Oshida
title_full_unstemmed	Artificial intelligence for medicine people, society, pharmaceuticals, and medical materials Yoshiki Oshida
title_short	Artificial intelligence for medicine
title_sort	artificial intelligence for medicine people society pharmaceuticals and medical materials
title_sub	people, society, pharmaceuticals, and medical materials
topic	Künstliche Intelligenz (DE-588)4033447-8 gnd Medizin (DE-588)4038243-6 gnd Arzneimittel (DE-588)4003115-9 gnd Gesellschaft (DE-588)4020588-5 gnd Medizinische Versorgung (DE-588)4038270-9 gnd Intelligenter Werkstoff (DE-588)4274825-2 gnd
topic_facet	Künstliche Intelligenz Medizin Arzneimittel Gesellschaft Medizinische Versorgung Intelligenter Werkstoff
url	https://www.degruyter.com/books/9783110717792 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032969182&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032969182&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT oshidayoshiki artificialintelligenceformedicinepeoplesocietypharmaceuticalsandmedicalmaterials AT walterdegruytergmbhcokg artificialintelligenceformedicinepeoplesocietypharmaceuticalsandmedicalmaterials

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Inhaltsverzeichnis
Inhaltsverzeichnis

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge